%0 Journal Article
%T A Phase 1 Study of CAL-101, An Isoform-Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, In Combination with Rituximab and/or Bendamustine In Patients with Relapsed or Refractory B-Cell Malignancies.
%A Flinn, Ian W.
%A Schreeder, Marshall T.
%A Wagner-Johnston, Nina
%A Boccia, Ralph V.
%A Leonard, John P.
%A Coutre, Steven E.
%A Holes, Leanne M.
%A Peterman, Sissy
%A Yu, Albert S.
%A ,
%J Blood
%V 116
%N 21
%P 2832-2832
%@ 0006-4971
%D 2010-11-19
%I American Society of Hematology
%~ DeepDyve